In an increasingly common practice, assistants, consultants and other hospital employees are charging patients or their insurers hefty fees. NYT reports.» Read More
China is preventing a GlaxoSmithKline executive from leaving the country as police accuse the British drugmaker of bribing officials and doctors, the drugmaker says.
Pharmaceutical and biotech stocks have outperformed markets this year, and with J&J's second-quarter earnings beat, investors may hope earnings will push stocks even higher.
Less than 90 days before Obamacare's government-run health exchanges are due to open up shop, Web insurers are still being locked out—a lag that could depress enrollment and jack up insurance rates.
Two breast-feeding-related companies are teaming up to help insurers comply with the new Obamacare rule entitling moms to free breast pumps and breast-feeding services.
Doctors in India work to calm the convulsions and keep the children hydrated, but then have to watch helplessly as their young patients die. The New York Times reports.
Johnson & Johnson reported higher-than-expected earnings as strong sales of prescription drugs and medical devices more than offset anemic growth of its consumer products.
In a recent study, fish oil proved dangerous for men who have high levels of the compounds because it raises the risk of prostate cancer.
Fresh off winning the NBA title with the Miami Heat, hoops legend Ray Allen is driving the lanes of Congress, asking for multi-year funding of diabetes research.
The Obama administration has come under fire for delaying some steps to verify the income of Americans seeking government subsidies for health insurance. But that doesn't mean there's no income verification.
Marijuana, though still considered controversial, continues to prove itself in as a successful prescription for neurological diseases that appear in children.
China is using "concerted" probes of foreign baby formula, pharmaceutical and packaging companies to bolster domestic firms, according to observers.
Health care stocks have been up almost across the board since 2010. Biotech and insurance names have been up triple digits. But political developments have put health care on a rockier path. CNBC's Kate Kelly breaks down the sector.
Fred Hutchinson Cancer Research Center released a study revealing men with concentrations of omega-3 fatty acids have an increased risk of prostate cancer. Co-author Alan Kristal shares more from their study on the best selling supplement.
Executives of British drug maker GlaxoSmithKline in China have confessed to charges of bribery and tax law violations, China's security ministry said on Thursday.
In a wide-ranging interview, Dick Parsons, former Time Warner chairman & CEO, shares his perspective on the banking industry and regulations; splitting the roles of chairman and CEO, and Tribune's separation.
One of the topics that will be discussed at next week's Delivering Alpha Conference will be the impact of Obamacare. CNBC's Kate Kelly takes a look at how hedge funds are playing it. And Eric Siegel, Citigroup, discusses his strategies on where he sees the best opportunities for investors now.
Can President Obama tinker with the law that was passed by Congress? Michael McConnell, Stanford Law Professor, and CNBC's Bertha Coombs discuss.
With six months of the year to go, investment professionals reveal how they're positioning themselves now.
Intuitive Surgical is down about 18 percent today after pre-announcing a huge miss Monday, CNBC's Herb Greenberg brings everyone up to speed; and Jason Mills, analyst at Canaccord Genuity, explains why he downgraded the stock.
Implementation of President Barack Obama's health-care law needs to be put on "permanent hold," GOP Sen. Bob Corker tells CNBC.
Get the best of CNBC in your inbox